Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)

China flag China · Delayed Price · Currency is CNY
14.53
-0.03 (-0.21%)
Nov 21, 2024, 9:51 AM CST
5.37%
Market Cap 23.15B
Revenue (ttm) 3.88B
Net Income (ttm) -422.97M
Shares Out 1.62B
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 26.79
Dividend 0.10 (0.69%)
Ex-Dividend Date Jul 8, 2024
Volume 566,544
Open 14.43
Previous Close 14.56
Day's Range 14.43 - 14.70
52-Week Range 10.45 - 16.40
Beta 0.52
Analysts n/a
Price Target n/a
Earnings Date Oct 29, 2024

About Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,451
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.